Recent therapeutic strategies for metastatic melanoma: introduction to invited articles Akifumi Yamamoto Invited Review Article 06 April 2018 Pages: 1507 - 1507
Recent advances in therapeutic strategies for unresectable or metastatic melanoma and real-world data in Japan Hisashi Uhara Invited Review Article 22 February 2018 Pages: 1508 - 1514
Tandem high-dose chemotherapy with topotecan–thiotepa–carboplatin and melphalan–etoposide–carboplatin regimens for pediatric high-risk brain tumors Jung Yoon ChoiHyoung Jin KangHee Young Shin Original Article 27 July 2019 Pages: 1515 - 1525
Prognostic relevance of ATM protein in uveal melanoma and its association with clinicopathological factors Jayanti JhaMithalesh Kumar SinghSeema Kashyap Original Article 03 August 2019 Pages: 1526 - 1535
Phonatory function in patients with well-differentiated thyroid carcinoma following meticulous resection of tumors adhering to the recurrent laryngeal nerve Satoru MiyamaruYoshihiko KumaiYorihisa Orita Original Article 24 June 2019 Pages: 1536 - 1542
Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II study Aya FukuizumiYuji MinegishiAkihiko Gemma Original Article 27 July 2019 Pages: 1543 - 1548
Validation of prognostic impact of number of extrathoracic metastases according to the eighth TNM classification: a single-institution retrospective study in Japan Kosuke SakaiJoji KuramotoKazutsugu Uematsu Original Article 26 August 2019 Pages: 1549 - 1557
Clinical impact of periodontal disease on postoperative complications in gastrointestinal cancer patients Mao NishikawaMichitaka HondaKanichi Seto Original Article 22 July 2019 Pages: 1558 - 1564
Gastrectomy for invasive micropapillary carcinoma is associated with poorer disease-free and disease-specific survival Mikihiro KanoJun HiharaTaijiro Sueda Original Article 20 July 2019 Pages: 1565 - 1573
A clinical trial to assess the feasibility and efficacy of nab-paclitaxel plus gemcitabine for elderly patients with unresectable advanced pancreatic cancer Rikiya HasegawaKosuke OkuwakiWasaburo Koizumi Original Article 15 July 2019 Pages: 1574 - 1581
Outcomes of non-metastatic colon cancer patients in relationship to socioeconomic status: an analysis of SEER census tract-level socioeconomic database Omar Abdel-Rahman Original Article 25 June 2019 Pages: 1582 - 1587
Peri-operative efficacy and long-term survival benefit of robotic-assisted radical cystectomy in septuagenarian patients compared with younger patients: a nationwide multi-institutional study in Japan Hideto IwamotoShuichi MorizaneHiroomi Kanayama Original Article 23 May 2019 Pages: 1588 - 1595
An open-label, phase 1 study of androgen receptor antagonist, apalutamide in Japanese patients with metastatic castration-resistant prostate cancer Tomohiro TsuchiyaKeiichiro ImanakaHiroji Uemura Original Article Open access 24 August 2019 Pages: 1596 - 1604
Prognostic analysis of surgically treated clear cell sarcoma: an analysis of a rare tumor from a single center Shiqi ChenPeng LuoChunmeng Wang Original Article Open access 26 June 2019 Pages: 1605 - 1611
Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer Mayumi SawadaTetsuro OishiTasuku Harada Original Article 24 June 2019 Pages: 1612 - 1619
Treatment-associated outcomes of patients with primary ocular adnexal MALT lymphoma after accurate diagnosis Yuya MasudaKazuto TakeuchiYoshihiro Yakushijin Original Article 06 June 2019 Pages: 1620 - 1628
Considering bone health in the treatment of prostate cancer bone metastasis based on the results of the ERA-223 trial Atsushi MizokamiGo KimuraKouji Izumi Letter to the Editor 03 September 2019 Pages: 1629 - 1631
